Podcast Beta
Questions and Answers
What is a primary clinical use of ciprofloxacin?
Which fluoroquinolone is specifically indicated for treating community-acquired pneumonia?
What adverse reaction is common to all fluoroquinolones?
Which fluoroquinolone is NOT indicated for the treatment of urinary tract infections?
Signup and view all the answers
Which generation of fluoroquinolones primarily covers only gram-negative bacteria?
Signup and view all the answers
How do fluoroquinolones' absorption properties change when taken with certain dietary supplements?
Signup and view all the answers
Which fluoroquinolone has enhanced activity against gram-positive organisms?
Signup and view all the answers
What is the mechanism of action for fluoroquinolones?
Signup and view all the answers
Which fluoroquinolone generation exhibits significantly enhanced activity against anaerobic bacteria?
Signup and view all the answers
Which of the following statements accurately describes the distribution of fluoroquinolones?
Signup and view all the answers
In the context of fluoroquinolones, what does the term 'bactericidal' refer to?
Signup and view all the answers
What characterizes the renal elimination of fluoroquinolones?
Signup and view all the answers
What type of bacteria is Levofloxacin particularly effective against?
Signup and view all the answers
What is one common mechanism by which bacteria develop resistance to fluoroquinolones?
Signup and view all the answers
Which option describes a characteristic of the 3rd generation fluoroquinolones?
Signup and view all the answers
What type of infections are commonly treated with fluoroquinolones?
Signup and view all the answers
Study Notes
Fluoroquinolones
- First-generation: primarily covers gram-negative bacteria (e.g., Nalidixic acid).
- Second-generation: covers some gram-positive bacteria, aerobic gram-negative bacteria, and atypical bacteria (e.g., Ciprofloxacin, Norfloxacin, Ofloxacin). They have significant intracellular penetration.
- Third-generation: covers a broader range of gram-positive bacteria, gram-negative bacteria, and atypical bacteria (e.g., Levofloxacin).
- Fourth-generation: covers gram-negative bacteria and has enhanced activity against anaerobic and gram-positive bacteria (e.g., Moxifloxacin).
Mechanism of Action
-
Inhibition of topoisomerase II (DNA gyrase):
- Prevents relaxation of positively supercoiled DNA
- Required for normal transcription and replication
- First and second-generation fluoroquinolones are more selective for this target.
-
Inhibition of topoisomerase IV:
- Interferes with chromosomal DNA separation during cell division
- Third and fourth-generation fluoroquinolones are more selective for this target.
Antimicrobial Spectrum
- Alternative for patients with severe β-lactam allergy
- Bactericidal
-
Effective against:
- Gram-positive bacteria: Streptococci
- Gram-negative bacteria: E. coli, P. aeruginosa, H. influenzae
- Atypical organisms: Legionellaceae, Chlamydiaceae
- Mycobacteria: M. tuberculosis
-
Respiratory fluoroquinolones:
- Levofloxacin and Moxifloxacin
- Excellent activity against S. pneumoniae, used for community-acquired pneumonia (CAP)
-
Commonly used to treat serious infections caused by:
- Klebsiella pneumoniae (Nosocomial pathogen)
- Other members of the Enterobacteriaceae family
Resistance
-
Altered target:
- Mutations in bacterial DNA gyrase and topoisomerase IV
- Decreased affinity for the target
-
Decreased Accumulation:
- Reduced porin proteins in the outer membrane
- Decreased energy-dependent efflux system in the cell membrane
Clinical Uses
-
Ciprofloxacin:
- Treats systemic infections caused by gram-negative bacilli
- Effective against P. aeruginosa, used in cystic fibrosis patients
- Treats traveler's diarrhea caused by E. coli and typhoid fever caused by S. typhi
-
Levofloxacin:
- Active against Streptococci
- Treats prostatitis, skin infections, CAP, and nosocomial pneumonia
- Excellent activity against pneumococcus
-
Moxifloxacin:
- Enhanced activity against gram-positive organisms (e.g., S. pneumoniae)
- Excellent activity against many anaerobes
- Does not concentrate in urine, not indicated for UTIs
Adverse Reactions
- Gastrointestinal: nausea, vomiting, diarrhea
- Central nervous system: headache, dizziness/lightheadedness
- Phototoxicity
- Peripheral neuropathy and glucose dysregulation (hypoglycemia)
- Tendonitis and tendon rupture: avoid use in pregnancy, lactation, and < 18 years old
Pharmacokinetics
-
Absorption:
- Well-absorbed orally, except for Norfloxacin (25-70% absorption)
- Reduced absorption if taken with sucralfate, antacids containing aluminum or magnesium, dietary supplements containing iron/zinc, and calcium products
-
Distribution:
- Plasma protein binding ranges from 10% to 40%
- Well distributed to all tissues and body fluids, except for CSF (Ofloxacin can cross the BBB well)
- High levels in bone, urine (except Moxifloxacin), kidney, prostatic tissue (but not prostatic fluid), and lungs
- Accumulate in macrophages and polymorphonuclear leukocytes (effective against intracellular organisms like Legionella pneumophila and Mycoplasma pneumoniae)
-
Elimination:
- Fluoroquinolones are excreted renally, except for Moxifloxacin.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
Explore the different generations of fluoroquinolones and their mechanisms of action. This quiz will test your knowledge about their specific uses against various bacteria and how they inhibit DNA processes. Perfect for pharmacy students or those interested in antimicrobial agents.
